Dis-Chem Pharmacies has reported strong financial results for the first half of 2024, showcasing a 16.3% increase in headline earnings per share (HEPS). The group’s focus on expansion and efficient cost management has significantly boosted its bottom line. Dis-Chem recorded a 9.6% rise in total revenue for the six months ending in August, reaching R19.6 billion. The retail segment saw…